712 results match your criteria Advances in internal medicine[Journal]


Peripheral arterial disease.

Adv Intern Med 2001 ;47:89-110

Department of Medicine, Section of Vascular Medicine, University of Colorado Health Sciences Center, Denver, USA.

View Article

Download full-text PDF

Source
June 2002
2 Reads

Cardiovascular effects of estrogen replacement therapy.

Authors:
C U Chae J E Manson

Adv Intern Med 2001 ;47:47-88

Harvard Medical School, Division of Preventive Medicine, Brigham and Women's Hospital, Cardiology Division, Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source

Advances in immune-based therapies to improve solid organ graft survival.

Adv Intern Med 2001 ;47:293-331

Office of Clinical Applications, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source

Infectious diseases of international travel.

Adv Intern Med 2001 ;47:265-92

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source
June 2002
3 Reads

Drug abuse and addiction in internal medicine.

Adv Intern Med 2001 ;47:239-63

Center on AIDS and Other Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source

Kidney stones.

Authors:
D A Bushinsky

Adv Intern Med 2001 ;47:219-38

University of Rochester School of Medicine and Dentistry, Nephrology Unit, Strong Memorial Hospital, Rochester, NY, USA.

View Article

Download full-text PDF

Source
June 2002
1 Read

Sjögren's syndrome: current concepts.

Adv Intern Med 2001 ;47:191-217

Department of Pathophysiology, School of Medicine, National University of Athens, Greece.

View Article

Download full-text PDF

Source

Therapeutic angiogenesis inhibitors in the treatment of cancer.

Adv Intern Med 2001 ;47:159-90

Division of Oncology, University of Texas Health Science Center at San Antonio, USA.

View Article

Download full-text PDF

Source
June 2002
2 Reads

Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma.

Adv Intern Med 2001 ;47:137-57

University of North Carolina School of Medicine, UNC Hospitals, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Authors:
M J Malloy J P Kane

Adv Intern Med 2001 ;47:111-36

Cardiovascular Research Institute, Pediatric Lipid Clinic, University of California, San Francisco, USA.

Compelling evidence from meta-analysis of a number of clinical studies on a large aggregate of patients has established an increased level of triglycerides as an independent risk factor for atherosclerotic heart disease. The finding of triglyceride-rich lipoproteins in human atheromata has provided substantial pathophysiologic evidence for a direct role in atherogenesis. Hypertriglyceridemia is commonly embedded in the context of a metabolic syndrome that includes central obesity, insulin resistance, low levels of HDL cholesterol, and often hypertension. Read More

View Article

Download full-text PDF

Source
June 2002
1 Read

Pathogenesis and treatment of cardiomyopathy.

Authors:
G C Fonarow

Adv Intern Med 2001 ;47:1-45

UCLA School of Medicine, Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, Calif., USA.

Dilated cardiomyopathy is a disease of diverse causes. Untreated, this condition will likely progress to advanced heart failure, sudden death, or both. There have been a number of significant advances in the understanding of the mechanisms involved in the pathogenesis of this disease. Read More

View Article

Download full-text PDF

Source

Update on the prevention, diagnosis, and treatment of Lyme disease.

Authors:
L T Hu M S Klempner

Adv Intern Med 2001 ;46:247-75

Tufts University School of Medicine, New England Medical Center, Boston, USA.

With our better understanding of Lyme disease, we now know it is not the "great imitator" of disease it once was thought to be. Limited, identifiable syndromes can be related to Lyme disease. Most of the disease's manifestations resolve without treatment. Read More

View Article

Download full-text PDF

Source
March 2001
1 Read

Colorectal cancer screening in average- and high-risk groups.

Authors:
D J Ahnen K L Lynch

Adv Intern Med 2001 ;46:77-106

University of Colorado School of Medicine, Denver, USA.

View Article

Download full-text PDF

Source

Prevention and treatment of influenza infections.

Authors:
D Iacuzio

Adv Intern Med 2001 ;46:51-76

Roche Laboratories Inc, Nutley, NJ, USA.

View Article

Download full-text PDF

Source

Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.

Adv Intern Med 2001 ;46:359-408

University of Colorado Health Sciences Center, Denver, USA.

View Article

Download full-text PDF

Source

Update on the management of asthma.

Adv Intern Med 2001 ;46:31-50

Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source

Advances in percutaneous coronary intervention.

Authors:
J J Pompa J C Wang

Adv Intern Med 2001 ;46:307-58

Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, USA.

View Article

Download full-text PDF

Source
March 2001
2 Reads

Disease management systems for chronic cardiovascular diseases: focus on heart failure.

Authors:
J A West R F DeBusk

Adv Intern Med 2001 ;46:295-306

Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif., USA.

View Article

Download full-text PDF

Source

Advances in the detection of residual thyroid carcinoma.

Adv Intern Med 2001 ;46:277-94

Cornell University, New York, USA.

The challenge of detecting and anatomically localizing metastatic thyroid cancer deposits has become less daunting with the recent developments in radionuclide technology. The use of serum Tg measurements and the whole body radioiodine scan remain the mainstays of the diagnostic evaluation. The advent of recombinant human TSH makes the preparation for a diagnostic scan much less burdensome and appears to have excellent sensitivity for serious metastatic lesions. Read More

View Article

Download full-text PDF

Source

Current strategies in the treatment of HIV infection.

Authors:
O J Cohen A S Fauci

Adv Intern Med 2001 ;46:207-46

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source

Update on the diagnosis and treatment of Wegener's granulomatosis.

Adv Intern Med 2001 ;46:177-206

Immunologic Diseases Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., USA.

View Article

Download full-text PDF

Source

The pathophysiology, diagnosis, and management of acute hepatic encephalopathy.

Adv Intern Med 2001 ;46:155-76

Department of Surgery, UCLA/Cedars-Sinai Medical Center, USA.

Acute hepatic encephalopathy is a disorder linked between the 2 most complex organs of the body and is clearly an integral aspect of acute liver failure. Its presence defines fulminant hepatic failure and its progression reflects the prognosis. For the scientist, the pathophysiology of this syndrome is a fascinating and active area of research, bridging numerous independent disciplines in new and creative ways. Read More

View Article

Download full-text PDF

Source
March 2001
1 Read

The rising incidence of esophageal adenocarcinoma.

Adv Intern Med 2001 ;46:137-53

Department of Internal Medicine, Section of Gastroenterology, University of Kansas and VA Medical Center, Kansas City, Mo., USA.

View Article

Download full-text PDF

Source

Drug therapy for hepatitis B.

Authors:
A Regev E R Schiff

Adv Intern Med 2001 ;46:107-35

Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, Miami, Fla., USA.

Until recently, IFN has been the only available therapy for chronic HBV infection; however, many new and exciting therapeutic strategies have emerged during the last decade. Recent advances in our understanding of the replicative mechanism of HBV and the development of potent nucleoside analogues have opened a new era in the treatment of HBV. Lamivudine has been introduced as an alternative to IFN, showing at least similar efficacy, but with a wider spectrum of indications and without the adverse effects. Read More

View Article

Download full-text PDF

Source

New abortive agents for the treatment of migraine.

Adv Intern Med 2001 ;46:1-29

Departments of Neurology and Anesthesiology, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source

Cytokine therapy of mycobacterial infections.

Authors:
S M Holland

Adv Intern Med 2000 ;45:431-52

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

More than a century after the discovery of tuberculosis, mycobacterial infections are resurgent. The recent identification of mutations affecting the control of mycobacteria offer critical insights into the pathways necessary for the control of intracellular pathogens and bring us several steps closer to understanding the basic mechanisms involved. Therapy, which until recently seemed simple and straightforward, is now complicated by the emergence of drug-resistant organisms and immunocompromised hosts. Read More

View Article

Download full-text PDF

Source
February 2000
1 Read

Prothrombotic effects of angiotensin.

Adv Intern Med 2000 ;45:419-29

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

In vitro and in vivo data provide compelling evidence for an interaction between the RAS and thrombosis. Furthermore, angiotensin and AT1 receptor blockers may influence platelet function. ACE is strategically poised to regulate these interactions. Read More

View Article

Download full-text PDF

Source
February 2000

Novel risk factors and markers for coronary disease.

Authors:
P M Ridker

Adv Intern Med 2000 ;45:391-418

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
February 2000
2 Reads

Obstructive sleep apnea.

Authors:
R B Fogel D P White

Adv Intern Med 2000 ;45:351-89

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
February 2000
1 Read

Advances in glucocorticoid therapy.

Authors:
J D Baxter

Adv Intern Med 2000 ;45:317-49

Metabolic Research Unit, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
February 2000

The adult growth hormone deficiency syndrome.

Adv Intern Med 2000 ;45:297-315

Oregon Health Sciences University, Portland, USA.

The diagnosis of the adult GH deficiency syndrome from a clinical and laboratory standpoint has been reviewed. Therapy guidelines and monitoring should focus on the patient's symptoms and IGF-1 concentrations from a laboratory standpoint. Successful patient/physician interaction depends on physician awareness of the symptoms of the deficiency syndrome and symptoms associated with therapy. Read More

View Article

Download full-text PDF

Source
February 2000

Classification of diabetes mellitus.

Adv Intern Med 2000 ;45:279-95

Yale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
February 2000

Selective estrogen receptor modulators and postmenopausal health.

Adv Intern Med 2000 ;45:259-78

University of California, Department of Medicine, San Francisco, USA.

SERMs are a class of drugs with mixed estrogen agonist/antagonist effects that have great potential at targeting changes seen in the postmenopausal period. Raloxifene is effective in preventing bone loss and may prevent fractures in postmenopausal osteoporosis. It induces changes in lipoprotein concentrations that should be cardioprotective. Read More

View Article

Download full-text PDF

Source
February 2000

Sarcoidosis: developments in etiology, immunology, and therapeutics.

Adv Intern Med 2000 ;45:209-57

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, USA.

View Article

Download full-text PDF

Source
February 2000
1 Read

Herpes simplex type 2 infections--an update.

Adv Intern Med 2000 ;45:175-208

Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
February 2000

The role of Chlamydia pneumoniae in cardiovascular disease.

Adv Intern Med 2000 ;45:139-73

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
February 2000

The systemic amyloidoses: an overview.

Authors:
R H Falk M Skinner

Adv Intern Med 2000 ;45:107-37

Boston University School of Medicine, Massachusetts, USA.

View Article

Download full-text PDF

Source
February 2000

Advances in the treatment of hepatitis C.

Authors:
S P Lawrence

Adv Intern Med 2000 ;45:65-105

University of Colorado Health Sciences Center, Denver, USA.

The health care burden caused by hepatitis C is projected to increase significantly in the next 20 years, on the basis of modeling estimates of cirrhosis, hepatic decompensation, and HCC likely to be seen in this population in the future. The number of cases of HCV-induced liver decompensation and mortality in the United States is projected to be approximately 4 times higher by the year 2018 than is currently seen, because of the aging of those presently infected. HCV also poses a significant quality-of-life decrement in the majority of individuals with chronic infection. Read More

View Article

Download full-text PDF

Source
February 2000
2 Reads

Early prostate cancer diagnosis and therapy.

Authors:
L M Glodé

Adv Intern Med 2000 ;45:41-64

University of Colorado School of Medicine, University of Colorado Cancer Center, Denver, USA.

View Article

Download full-text PDF

Source
February 2000

Advances in HIV/AIDS therapy.

Adv Intern Med 2000 ;45:1-40

Department of Medicine, University Hospital HIV/AIDS Clinical Program, University of Colorado Health Sciences Center, Denver, USA.

Advances in HIV/AIDS therapy have been rapid and profound. An improved understanding of HIV pathogenesis has demonstrated the need for aggressive antiretroviral therapy in most persons with HIV infection. Combinations of at least three drugs are necessary to fully suppress viral replication. Read More

View Article

Download full-text PDF

Source
February 2000
2 Reads

Ethics and genetic testing.

Authors:
C Grady

Adv Intern Med 1999 ;44:389-411

Department of Clinical Bioethics, W.G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

The tremendous growth in knowledge about genes and genetic technologies will eventually enable us to know individual genotypes and susceptibilities to disease, perhaps even before birth. Each new genetic test developed raises serious issues for individuals and society on the circumstances under which genetic information should be sought and the uses that should be made of such information. Ethical reflection and analysis will help us to prepare for the responsible use of information about genotypes so that individuals, both now and in the future, are benefited and not harmed, so that justice is served, and so that confidentiality and privacy, and respect for the autonomy, dignity, and differences of each individual, are preserved. Read More

View Article

Download full-text PDF

Source

Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection.

Adv Intern Med 1999 ;44:353-88

Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source

Adult immunization: principles and practice.

Adv Intern Med 1999 ;44:327-52

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source

Thrombolytic therapy.

Authors:
S Z Goldhaber

Adv Intern Med 1999 ;44:311-25

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
March 1999
1 Read

Myocarditis.

Authors:
J W Mason

Adv Intern Med 1999 ;44:293-310

Department of Medicine, University of Utah School of Medicine, Salt Lake City, USA.

View Article

Download full-text PDF

Source

Diseases of the aorta.

Adv Intern Med 1999 ;44:267-91

Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source

Atrial fibrillation and anticoagulation.

Adv Intern Med 1999 ;44:239-65

Stanford University School of Medicine, Palo Alto, California, USA.

View Article

Download full-text PDF

Source

Newer therapeutic agents for asthma.

Authors:
A Deykin E Israel

Adv Intern Med 1999 ;44:209-37

Harvard Medical School, Boston, Massachusetts, USA.

The past decade has seen significant advances in the available treatments for asthma. These include longer-acting bronchodilating agents, high topical potency inhaled corticosteroids, and agents that interfere with leukotriene production or action. Table 3 summarizes the clinical effects of the newer therapeutic agents reviewed. Read More

View Article

Download full-text PDF

Source

Management of osteoporosis.

Authors:
P D Miller

Adv Intern Med 1999 ;44:175-207

University of Colorado Health Sciences Center, Denver, USA.

View Article

Download full-text PDF

Source
March 1999
1 Read

Congenital adrenal hyperplasia in the adult patient.

Authors:
W L Miller

Adv Intern Med 1999 ;44:155-73

Department of Pediatrics, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source